The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 |
doi: 10.3389/fmolb.2024.1459242
This article is part of the Research Topic Immune Infiltration and Immunotherapy in Cancer Studies View all 9 articles
Immune Infiltration and Immunotherapy in Cancer Studies
Provisionally accepted- 1 Boston University, Boston, United States
- 2 Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, Cornell University, New York, New York, United States
- 3 Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
Keywords: Immunotherapy, Immune infiltration, Tumor microenvironment (TME), Pan-cancer analysis, Cancer prognosis, Biomarker Analysis etc
Received: 03 Jul 2024; Accepted: 07 Aug 2024.
Copyright: © 2024 Goyal, BHATTACHARYA and CHAUHAN. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Manish Goyal, Boston University, Boston, United States
UDAYAN BHATTACHARYA, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, Cornell University, New York, 10065, New York, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.